デフォルト表紙
市場調査レポート
商品コード
1433570

造影超音波市場の市場規模、シェア、動向分析レポート:製品タイプ別、最終用途別、地域別、セグメント別予測、2024年~2030年

Contrast Enhanced Ultrasound Market Size, Share & Trends Analysis Report By Product, By Type, By End-use, By Region, And Segment Forecasts, 2024 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 130 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.54円
造影超音波市場の市場規模、シェア、動向分析レポート:製品タイプ別、最終用途別、地域別、セグメント別予測、2024年~2030年
出版日: 2024年01月09日
発行: Grand View Research
ページ情報: 英文 130 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

造影超音波市場の成長と動向:

造影超音波の世界市場は、2030年までに29億9,000万米ドルに達すると予測されています。

Grand View Research, Inc.の最新レポートによると、2024年~2030年のCAGRは5.70%で成長すると予測されています。心血管疾患、がん、肝疾患などの慢性疾患の有病率の上昇、高齢者人口の増加、超音波イメージング技術における技術進歩の増加が、予測期間における造影超音波市場の成長を促進すると予測される主な要因です。CTやMRIのような他のイメージングモダリティよりも造影超音波を使用した方が、低コスト、携帯性、電離放射線を使用しないことから、市場の成長はさらに促進されます。

心血管疾患の有病率の上昇が市場成長に拍車をかけています。世界保健機関(WHO)によると、心血管疾患が原因で毎年推定1,790万人が死亡しており、世界の死因の第1位となっています。2022年には、心血管疾患と診断される人の増加が予想されます。そこで、造影超音波(CEUS)がこれらの疾患の発見とモニタリングに重要な役割を果たします。CEUSは超音波画像を強調する造影剤を使用し、心臓や血管をより鮮明に描出します。心臓弁膜症、大動脈瘤、末梢動脈疾患などの診断に使用できます。

さらに、CEUSは電離放射線を使用しない非侵襲的で安全な画像診断法です。そのため、電離放射線を使用するCTやMRIのような他の画像モダリティよりも好ましい選択肢となっています。2021年、Journal of the American College of Cardiology誌に発表された研究では、CEUSは他の画像モダリティと比較して冠動脈疾患の検出において高い診断精度を有することが示されました。多くの利点を持つCEUSは、心血管疾患の診断と管理においてますます重要なツールになりつつあります。

造影超音波市場レポートハイライト:

  • 製品別では、機器セグメントが2023年に最大の収益シェアを占めました。これは、CEUSと互換性のある超音波イメージング技術のインストールベースが最大であることに起因します。
  • 造影剤セグメントは、FDAによる肝臓および小児画像診断での使用承認により、予測期間中にCAGR 6.32%の急成長が期待されます。
  • タイプ別では、市販造影剤のほとんどが非標的であるため、非標的セグメントが2023年に最大の収益シェアを占めました。
  • 病院セグメントは、腹痛、腹部/胸部外傷、心臓合併症などの病状による救急受診の増加により、2023年に最大の市場シェアを占めました。
  • 診療所セグメントは、一次および二次医療の医師がソノグラフィ機器を導入することで経済的および患者ケア上のメリットを実感していることから、予測期間中に有利なCAGRを記録すると予測されています。
  • アジア太平洋では、CTやMRIのような先進的なCT/MRI画像モダリティへのアクセスが限られていること、中国やインドで心血管障害の負担が増加していることから、市場は最も速いCAGRで成長すると予想されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 造影超音波市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 造影超音波市場分析ツール
    • 業界分析 - ポーターのファイブフォース分析
    • PESTEL分析

第4章 造影超音波市場:製品別の推定・動向分析

  • 製品別の市場シェア(2023年・2030年)
  • セグメントダッシュボード
  • 製品別の世界の造影超音波市場の見通し
  • 市場規模、予測および動向分析(2018年~2030年)

第5章 造影超音波市場:タイプ別の推定・動向分析

  • タイプ別の市場シェア(2023年・2030年)
  • セグメントダッシュボード
  • タイプ別の世界の造影超音波市場の見通し
  • 市場規模、予測および動向分析(2018年~2030年)

第6章 造影超音波市場:最終用途別の推定・動向分析

  • 最終用途別の市場シェア(2023年・2030年)
  • セグメントダッシュボード
  • 最終用途別の世界の造影超音波市場の見通し
  • 市場規模、予測および動向分析(2018年~2030年)

第7章 造影超音波市場:地域別の推定・動向分析

  • 地域別の市場シェア分析(2023年・2030年)
  • 地域別の市場ダッシュボード
  • 地域別の市場スナップショット
  • 市場規模、予測および動向分析(2018年~2030年)
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
  • ベンダー情勢
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
    • Lantheus Medical Imaging, Inc.
    • GE Healthcare
    • Bracco Diagnostic
    • GE HealthCare
    • Siemens Healthcare GmbH
    • Koninklijke Philips NV
    • CANON MEDICAL SYSTEMS CORPORATION
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America contrast enhanced ultrasound market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 5 North America contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S. contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 8 U.S. contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 11 Canada contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe contrast enhanced ultrasound market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 14 Europe contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 15 Europe contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Germany contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 17 Germany contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 18 Germany contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 21 UK contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 23 France contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 24 France contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 27 Italy contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 30 Spain contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Denmark contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 32 Denmark contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 33 Denmark contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Sweden contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 35 Sweden contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 36 Sweden contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Norway contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 38 Norway contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 39 Norway contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific contrast enhanced ultrasound market, by region, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 China contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 45 China contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 46 China contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Japan contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 48 Japan contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 49 Japan contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 India contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 51 India contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 52 India contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 South Korea contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 54 South Korea contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 55 South Korea contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 Australia contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 57 Australia contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 58 Australia contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Thailand contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 60 Thailand contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 61 Thailand contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Latin America contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 63 Latin America contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 64 Latin America Non-targeted market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Latin America market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Latin America Targeted market, by end-use, 2018 - 2030 (USD Million)
  • Table 67 Latin America contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 68 Brazil contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 69 Brazil contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 70 Brazil Non-targeted market, by end-use, 2018 - 2030 (USD Million)
  • Table 71 Brazil market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Brazil Targeted market, by end-use, 2018 - 2030 (USD Million)
  • Table 73 Brazil contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 Mexico contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 75 Mexico contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 76 Mexico Non-targeted market, by end-use, 2018 - 2030 (USD Million)
  • Table 77 Mexico market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 Mexico Targeted market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 Mexico contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 80 Argentina contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 81 Argentina contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 82 Argentina Non-targeted market, by end-use, 2018 - 2030 (USD Million)
  • Table 83 Argentina market, by end-use, 2018 - 2030 (USD Million)
  • Table 84 Argentina Targeted market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 Argentina contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 MEA contrast enhanced ultrasound market, by region, 2018 - 2030 (USD Million)
  • Table 87 MEA contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 88 MEA contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 89 MEA contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 South Africa contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 91 South Africa contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 92 South Africa contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 93 Saudi Arabia contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 94 Saudi Arabia contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 95 Saudi Arabia contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 96 UAE contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 97 UAE contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 98 UAE contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 99 Kuwait contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 100 Kuwait contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 101 Kuwait contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Contrast enhanced ultrasound market: market outlook
  • Fig. 14 Contrast enhanced ultrasound market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Contrast enhanced ultrasound market driver impact
  • Fig. 20 Contrast enhanced ultrasound market restraint impact
  • Fig. 21 Contrast enhanced ultrasound market strategic initiatives analysis
  • Fig. 22 Contrast enhanced ultrasound market: Product movement analysis
  • Fig. 23 Contrast enhanced ultrasound market: Product outlook and key takeaways
  • Fig. 24 Equipment market estimates and forecast, 2018 - 2030
  • Fig. 25 Contrast agents estimates and forecast, 2018 - 2030
  • Fig. 26 Contrast enhanced ultrasound market: Type movement Analysis
  • Fig. 27 Contrast enhanced ultrasound market: Type outlook and key takeaways
  • Fig. 28 Non-targeted market estimates and forecasts, 2018 - 2030
  • Fig. 29 Targeted market estimates and forecasts,2018 - 2030
  • Fig. 30 Contrast enhanced ultrasound market: end-use movement analysis
  • Fig. 31 Contrast enhanced ultrasound market: end-use outlook and key takeaways
  • Fig. 32 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 33 Clinics market estimates and forecasts,2018 - 2030
  • Fig. 34 Ambulatory diagnostic centers market estimates and forecasts, 2018 - 2030
  • Fig. 35 Global contrast enhanced ultrasound market: Regional movement analysis
  • Fig. 36 Global contrast enhanced ultrasound market: Regional outlook and key takeaways
  • Fig. 37 Global contrast enhanced ultrasound market share and leading players
  • Fig. 38 North America market share and leading players
  • Fig. 39 Europe market share and leading players
  • Fig. 40 Asia Pacific market share and leading players
  • Fig. 41 Latin America market share and leading players
  • Fig. 42 Middle East & Africa market share and leading players
  • Fig. 43 North America: SWOT
  • Fig. 44 Europe SWOT
  • Fig. 45 Asia Pacific SWOT
  • Fig. 46 Latin America SWOT
  • Fig. 47 MEA SWOT
  • Fig. 48 North America
  • Fig. 49 North America market estimates and forecasts, 2018 - 2030
  • Fig. 50 U.S.
  • Fig. 51 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 52 Canada
  • Fig. 53 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 54 Europe
  • Fig. 55 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 56 UK
  • Fig. 57 UK market estimates and forecasts, 2018 - 2030
  • Fig. 58 Germany
  • Fig. 59 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 60 France
  • Fig. 61 France market estimates and forecasts, 2018 - 2030
  • Fig. 62 Italy
  • Fig. 63 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 64 Spain
  • Fig. 65 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 66 Denmark
  • Fig. 67 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 68 Sweden
  • Fig. 69 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 70 Norway
  • Fig. 71 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 72 Asia Pacific
  • Fig. 73 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 74 China
  • Fig. 75 China market estimates and forecasts, 2018 - 2030
  • Fig. 76 Japan
  • Fig. 77 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 78 India
  • Fig. 79 India market estimates and forecasts, 2018 - 2030
  • Fig. 80 Thailand
  • Fig. 81 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 82 South Korea
  • Fig. 83 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 84 Australia
  • Fig. 85 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 86 Latin America
  • Fig. 87 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 88 Brazil
  • Fig. 89 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 90 Mexico
  • Fig. 91 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 92 Argentina
  • Fig. 93 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 94 Middle East and Africa
  • Fig. 95 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 96 South Africa
  • Fig. 97 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 98 Saudi Arabia
  • Fig. 99 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 100 UAE
  • Fig. 101 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 102 Kuwait
  • Fig. 103 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 104 Market share of key market players- Contrast enhanced ultrasound market
目次
Product Code: GVR-4-68039-141-1

Contrast Enhanced Ultrasound Market Growth & Trends:

The global contrast enhanced ultrasound market is anticipated to reach USD 2.99 billion by 2030. It is projected to grow at a CAGR of 5.70% from 2024 - 2030, according to a new report by Grand View Research, Inc. The rising prevalence of chronic disorders such as cardiovascular ailments, cancer, and liver disease, growing geriatric population, and increasing technological advancements in the ultrasound imaging technology are the major factors anticipated to boost the contrast-enhanced ultrasound market growth over the forecast period. Growth in the market is further propelled using contrast-enhanced ultrasound over other imaging modalities like CT and MRI has become more popular due to its lower cost, portability, and lack of ionizing radiation.

The rising prevalence of cardiovascular diseases fueling the market growth. According to the World Health Organization (WHO), an estimated 17.9 million deaths occur each year due to cardiovascular diseases, making it the leading cause of death globally. In 2022, it is expected that there will be an increase in the number of people diagnosed with cardiovascular diseases. This is where contrast-enhanced ultrasound (CEUS) can play a crucial role in helping to detect and monitor these conditions. CEUS uses a contrast agent that enhances the ultrasound image, allowing for better visualization of the heart and blood vessels. It can be used to diagnose conditions such as heart valve disease, aortic aneurysm, and peripheral artery disease.

Furthermore, CEUS is a non-invasive and safe imaging modality that does not use ionizing radiation. This makes it a preferred option over other imaging modalities like CT and MRI, which use ionizing radiation. In 2021, a study published in the Journal of the American College of Cardiology showed that CEUS had high diagnostic accuracy in detecting coronary artery disease compared to other imaging modalities. With its many benefits, CEUS is becoming an increasingly important tool in diagnosing and managing cardiovascular diseases.

Contrast Enhanced Ultrasound Market Report Highlights:

  • Based on product, the equipment segment held the largest revenue share in 2023. This can be attributed to the largest installed base of ultrasound imaging technology compatible with CEUS.
  • The contrast agents segment is expected to grow at the fastest CAGR of 6.32% during the forecast period owing to its approval of usage in the liver and pediatric imaging by the FDA.
  • Based on type, the non-targeted segment held the largest revenue share in 2023 as most of the commercially available contrast agents are non-targeted in nature.
  • The hospitals segment held the largest market share in 2023 owing to the increasing number of emergency visits with medical conditions such as abdominal pain, abdominal/thoracic trauma, and cardiac complications
  • The clinics segment is anticipated to witness lucrative CAGR over the forecast period owing to the realization of economic and patient care benefits with the adoption of sonography devices in practice among physicians at primary and secondary care
  • In Asia Pacific, the market is expected to grow at the fastest CAGR owing to the limited accessibility to advanced CT/MRI imaging modalities such as CT and MRI, and the growing burden of cardiovascular disorders in China and India.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Type
    • 1.2.3. End-use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Type outlook
    • 2.2.3. End-use
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Contrast Enhanced Ultrasound Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic disorders
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Extension of indications for use
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Low stability of the contrast agents
      • 3.2.2.2. Procedural complexity
      • 3.2.2.3. Availability of alternatives
  • 3.3. Contrast Enhanced Ultrasound Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Contrast Enhanced Ultrasound Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Contrast Enhanced Ultrasound Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Equipment
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Contrast Agents
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Contrast Enhanced Ultrasound Market: Type Estimates & Trend Analysis

  • 5.1. Type Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Contrast Enhanced Ultrasound Market by Type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Non-targeted
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Targeted
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Contrast Enhanced Ultrasound Market: End-use Estimates & Trend Analysis

  • 6.1. End-use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Contrast Enhanced Ultrasound Market by End-use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Hospitals
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Clinics
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Ambulatory Diagnostic Centers
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Contrast Enhanced Ultrasound Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Mexico
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework/reimbursement structure
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Lantheus Medical Imaging, Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. GE Healthcare
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Bracco Diagnostic
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. GE HealthCare
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Siemens Healthcare GmbH
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Koninklijke Philips N.V.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. CANON MEDICAL SYSTEMS CORPORATION
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives